Australian Cannabis Policy & Law
DOJ Rescheduling Order: Analyzing 280E Tax Implications for Medical Cannabis Businesses
The U.S. Department of Justice's April 2026 medical cannabis rescheduling order offers potential 280E tax relief for qualifying operators. Understand the…
Access & Prescribing (Australia & Global)
GCNC and Whitney Economics Report Details Europe’s Expanding Role in Global Medical Cannabis Market
A new GCNC and Whitney Economics report details the expansion of the European medical cannabis market, examining regulatory evolution, international trade…
Access & Prescribing (Australia & Global)
Sourcing Challenges for Ibogaine May Slow US Veterans’ Psychedelic Therapy Push
The US Department of Veterans Affairs is advancing psychedelic therapy for veterans, but sourcing ibogaine for research presents a significant hurdle. Lea…
Access & Prescribing (Australia & Global)
New Telehealth Platform Aims to Streamline Prescription CBD Access in the US
A new telehealth platform in the US aims to provide a regulated clinical pathway for prescription CBD access, offering clinician-led consultations and pha…
Access & Prescribing (Australia & Global)
Modern Canna Expands Cannabis Quality Solutions with Strategic Investment in CannaGuard PRO
Modern Canna expands its suite of cannabis quality solutions with a strategic investment in CannaGuard PRO, integrating EPA-registered sanitation for comm…
Australian Cannabis Policy & Law
Vireo Growth Inc. Announces Intent to Acquire Bridgewell Agribusiness for Estimated US$10.26 Million
Vireo Growth Inc. announced its intent to acquire Bridgewell Agribusiness LLC for an estimated US$10.26 million, expanding its footprint in the organic an…
Equities, Investment & Market Trends
Congressional Inaction Expected on US Hemp THC Product Ban, Industry Faces Significant Restructuring
The US hemp industry faces a significant challenge as Congress is unlikely to prevent a new federal hemp THC product ban from taking effect in November, a…
Equities, Investment & Market Trends
Curaleaf Announces 1-for-3 Reverse Stock Split in Preparation for U.S. Exchange Uplisting Amid Rescheduling Developments
Curaleaf Holdings Inc. (CURA) announced a 1-for-3 reverse stock split, effective June 5, 2026, to meet U.S. exchange criteria for uplisting. This move ant…
Access & Prescribing (Australia & Global)
Federal Medical Cannabis Rescheduling Prompts State-Level Policy Reassessment and Market Shifts
Explore how federal medical cannabis rescheduling to Schedule III is influencing state-level policy, potentially expanding access, and reshaping market dy…
Clinical Trials & Medical Research
New Study Suggests Cannabinoids May Offer Relief for Chronic Pain Conditions Including Fibromyalgia and Arthritis
New research indicates medical cannabis, including both THC and non-intoxicating cannabinoids, may significantly improve chronic pain symptoms for patient…
